Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders

Por Domi, E, Barbier, E, Augier, E, Augier, G, Gehlert, D, Barchiesi, R, Thorsell, A, Holm, L, Heilig, M
Publicado no Neuropsychopharmacology (2018)